Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

KOSDAQ/464280 stock hub

KOSDAQ/464280 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/464280is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

46.6B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/464280

In the news

Latest news · KOSDAQ/464280

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E10.4

P25 12P50 23.1P75 39.5

ROE10.5

P25 -17.1P50 0.7P75 8.5

ROIC13.6

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/464280 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

KRW

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 34.1B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	KR7464280007
Last refreshed	2026-05-10
Market cap	KRW 46.6B
Price	KRW 8,430
Price currency	KRW
Sector	Healthcare
Sic	2834
Symbol	kosdaq/464280
Website	https://www.tdspharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.17%
EV Earnings	7.98x
EV/EBIT	9.06x
EV/EBITDA	7.64x
EV/FCF	-3.75x
EV/Sales	1.24x
FCF yield	-19.53%
P/B ratio	1.09x
P/E ratio	10.43x
P/S ratio	1.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.63%
EBITDA Margin	16.16%
Gross margin	27.11%
Gross Profit	KRW 7.5B
Gross Profit Growth	-2.75%
Gross Profit Growth Q	72.35%
Gross Profit Growth3 Y	84.06%
Net Income	KRW 4.3B
Net Income Growth	14.98%
Net Income Growth Q	166.72%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	18%
Profit Margin	15.48%
Profitable Years	6
ROA	4.56
Roa5y	6.7
ROCE	8.77
ROE	10.52
Roe5y	15.62
ROIC	13.56
Roic5y	19.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-30.98%
EPS Growth	0.62
EPS Growth Q	166.5
EPS Growth Quarters	2
EPS Growth Years	1
OCF Growth	-3.79%
OCF Growth3 Y	52.62%
Revenue Growth	0.37x
Revenue Growth Q	54.47x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	15.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.53
Assets	KRW 54.2B
Cash	KRW 20.2B
Current Assets	KRW 29.8B
Current Liabilities	KRW 11.2B
Debt	KRW 7.7B
Debt EBITDA	KRW 1.73
Debt Equity	KRW 0.18
Debt FCF	KRW -0.85
Equity	KRW 42.8B
Interest Coverage	16.9
Liabilities	KRW 11.4B
Long Term Assets	KRW 24.3B
Long Term Liabilities	KRW 160.5M
Net Cash	KRW 12.5B
Net Cash By Market Cap	KRW 26.82
Net Cash Growth	-47.43%
Net Debt EBITDA	KRW -2.8
Net Debt Equity	KRW -0.29
Tangible Book Value	KRW 42.7B
Tangible Book Value Per Share	KRW 8,055

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.66
Inventory Turnover	7
Net Working Capital	KRW 6B
Quick ratio	2.4
Working Capital	KRW 18.6B
Working Capital Turnover	KRW 1.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-30.96%
200-day SMA	9,679.8
50-day SMA	8,881
50-day SMA vs 200-day SMA	50under200
All Time High	60,700
All Time High Change	-86.11%
All Time High Date	2024-08-22
All Time Low	7,950
All Time Low Change	6.04%
All Time Low Date	2026-04-07
ATR	404.6
Beta1y	0.34
Beta2y	0.11
Ch YTD	-14.42
High	8,690
High52	12,870
High52 Date	2025-05-13
High52ch	-34.5%
Low	8,360
Low52	7,950
Low52 Date	2026-04-07
Low52ch	6.04%
Ma50ch	-5.08%
Price vs 200-day SMA	-12.91%
RSI	41.31
RSI Monthly	13.62
RSI Weekly	39.54
Sharpe ratio	-0.88x
Sortino ratio	-1.22
Total Return	-14.26%
Tr YTD	-14.42
Tr1m	5.38%
Tr1w	-4.96%
Tr3m	-10.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 3.8B
Operating Income Growth	0.95
Operating Income Growth Q	442.6
Operating margin	13.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,946,137%
Net Borrowing	730,821,420
Shares Insiders	46.27%
Shares Institutions	4.27%
Shares Out	5,530,000
Shares Qo Q	0.13%
Shares Yo Y	14.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -9.1B
Average Volume	22,672x
Bv Per Share	8,079.4
CAPEX	KRW -12.9B
Ch1m	5.38
Ch1w	-4.96
Ch1y	-30.96
Ch3m	-10.32
Ch6m	-2.32
Change	0%
Change From Open	-0.82
Close	8,430
Days Gap	0.83
Depreciation Amortization	699,573,250
Dollar Volume	197,573,910
EBIT	KRW 3.8B
EBITDA	KRW 4.5B
EPS	KRW 808
F Score	3
FCF	KRW -9.1B
FCF EV Yield	-26.68x
FCF Per Share	KRW -1,646
Financing CF	730,821,420
Fiscal Year End	December
Founded	2,002
Graham Number	12119.53389
Graham Upside	43.77
Income Tax	KRW 698.1M
Investing CF	-8,002,502,830
Is Primary Listing	1
Last Report Date	2025-12-31
Ma150	9,349.1
Ma150ch	-9.83%
Ma20	8,747.5
Ma20ch	-3.63%
Net CF	-3,491,631,870
Open	8,500
P OCF Ratio	12.33
Position In Range	21.21
Ppne	20,728,505,780
Price Date	2026-05-08
Price EBITDA	KRW 10.44
Ptbv Ratio	1.09
Relative Volume	1.07x
Revenue	27,620,873,500x
Tax By Revenue	2.53x
Tax Rate	14.04%
Tr6m	-2.32%
Volume	23,437
Z Score	5.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/464280 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/464280 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/464280?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+46.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.3%

Negative means the company is buying back shares.

Technical

KOSDAQ/464280 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.3

Neutral momentum band

Price vs 200-day MA

-12.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/464280

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/464280 stock rating?

kosdaq/464280 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/464280 analysis?

The full report lives at /stocks/kosdaq/464280/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/464280?

The latest report frames kosdaq/464280 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/464280 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.